Goldman Sachs Group Inc. grew its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 9.5% in the 4th quarter, Holdings Channel reports. The fund owned 657,073 shares of the technology company’s stock after acquiring an additional 57,216 shares during the period. Goldman Sachs Group Inc.’s holdings in Veeva Systems were worth $146,678,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Jensen Investment Management Inc. raised its holdings in shares of Veeva Systems by 1,924.5% during the third quarter. Jensen Investment Management Inc. now owns 413,213 shares of the technology company’s stock valued at $123,100,000 after buying an additional 392,802 shares during the last quarter. Alphinity Investment Management Pty Ltd bought a new position in Veeva Systems in the 3rd quarter worth approximately $422,241,000. Robeco Institutional Asset Management B.V. increased its position in Veeva Systems by 11.3% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 892,070 shares of the technology company’s stock valued at $199,137,000 after acquiring an additional 90,703 shares during the period. Elo Mutual Pension Insurance Co increased its position in Veeva Systems by 50.2% in the 3rd quarter. Elo Mutual Pension Insurance Co now owns 26,541 shares of the technology company’s stock valued at $7,907,000 after acquiring an additional 8,869 shares during the period. Finally, Empire Life Investments Inc. raised its stake in Veeva Systems by 21.1% during the 4th quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company’s stock valued at $8,272,000 after acquiring an additional 6,453 shares in the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.
Veeva Systems Stock Performance
VEEV opened at $172.96 on Monday. The company has a market capitalization of $28.25 billion, a PE ratio of 30.83, a P/E/G ratio of 0.76 and a beta of 0.95. The stock’s fifty day moving average is $166.17 and its 200-day moving average is $195.17. Veeva Systems Inc. has a one year low of $148.05 and a one year high of $310.50.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the company. Raymond James Financial reissued an “outperform” rating and issued a $225.00 price target on shares of Veeva Systems in a research note on Thursday. Truist Financial restated a “buy” rating and set a $262.00 price objective (down from $275.00) on shares of Veeva Systems in a research note on Thursday, March 5th. BMO Capital Markets decreased their target price on shares of Veeva Systems from $220.00 to $175.00 and set a “market perform” rating for the company in a research report on Thursday. Barclays lowered their target price on shares of Veeva Systems from $250.00 to $235.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, Oppenheimer restated an “outperform” rating and set a $225.00 price target on shares of Veeva Systems in a research report on Thursday. Eighteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $250.96.
Read Our Latest Research Report on VEEV
Insider Buying and Selling at Veeva Systems
In other news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction dated Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares in the company, valued at approximately $506,296.92. This trade represents a 18.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.60% of the company’s stock.
Veeva Systems News Roundup
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva beat Q1 earnings and revenue estimates, with EPS of $2.24 and revenue of $882.9 million, while also raising its fiscal 2027 outlook. Veeva Systems beats estimates on AI progress
- Positive Sentiment: Management highlighted AI momentum, including Falcon AI agents, CRM migration wins, and the Ostro acquisition, suggesting new growth drivers beyond the core platform. Veeva Systems Q1 Earnings Call Highlights AI Push & Higher Outlook
- Positive Sentiment: Several brokers remained constructive, including Barclays, Oppenheimer, RBC, Needham, BTIG, and Robert W. Baird, many of which kept buy/outperform ratings and elevated price targets. Veeva Systems (VEEV) Receives a Buy from Barclays
- Neutral Sentiment: Citigroup raised its target to $190 and maintained a neutral stance, while UBS and Canaccord also trimmed targets but stayed at neutral/hold, reflecting a more mixed Street view. Analyst updates
- Negative Sentiment: Despite the beat-and-raise quarter, the stock sold off as investors likely questioned how much of the AI optimism is already priced in and whether legacy CRM migration dynamics could pressure growth. Is Veeva Stock Undervalued At $170?
- Negative Sentiment: Goldman Sachs cut its price target to $165 and kept a sell rating, adding to the cautious tone around the name. Veeva Systems price target lowered by Goldman Sachs
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
